Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20-90
SponsorFirst Affiliated Hospital of Kunming Medical University

About this trial

Retrospective clinical case studies in recent years have shown that most cases of lung cancer and abdominal aortic aneurysm (AAA) are detected at the same time and that there is a wide variation in the prevalence of AAA in patients with primary lung cancer reported in the literature, with some papers suggesting as high as 11%, suggesting that there may be a relationship between the prevalence of the two diseases. However, its exact incidence and mechanism are unknown. Accurate prevention of AAA in patients with primary lung cancer requires more in-depth studies. To solve the above problems, a multi-center prospective epidemiological investigation and mechanism study on the association of AAA in primary lung cancer combined has become particularly urgent. The results of the study will be of great significance for the follow-up treatment and prognosis of lung cancer patients as well as the improvement of long-term survival rate of lung cancer patients, and will also provide scientific basis and clinical guidance for the screening and prevention of AAA in lung cancer patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients diagnosed with primary lung cancer through clinical or pathological examination

Disqualifiers

Patients diagnosed with primary lung cancer who refuse to undergo abdominal aortic imaging screening.

Trial population

The selected subjects for the study were all patients diagnosed with primary lung cancer at the First Affiliated Hospital of Kunming Medical University and the Third Affiliated Hospital of Kunming Medical University from 1st October 2022 to 30 st April 2025, with an estimated sample size of about 2000 people. Detailed epidemiological data and long-term follow-up data were collected and analyzed, and epidemiological investigations were conducted.

Trial design

Design model

Case-only

Time perspective

Cross-sectional

Treatments tested in this trial

  • Ultrasound or CT of the abdominal aorta

    Device

    Patient underwent ultrasound or CT of the abdominal aorta

Treatment groups

2,000 Participants
are divided into 1 treatment group
Group A: Primary lung cancer with concomitant abdominal aortic aneurysm1 intervention

Trial outcomes

Primary outcomes

1

Incidence of abdominal aortic aneurysm in patients with primary lung cancer

Incidence of abdominal aortic aneurysm in patients with primary lung cancer

Time frame
2022-10-01 to 2025-04-30

Secondary outcomes

1

Epidemiological analysis

Common pathogenic factors of primary lung cancer with concomitant abdominal aortic aneurysm

Time frame
2022-10-01 to 2025-04-30

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

First Affiliated Hospital of Kunming Medical University

Lead sponsor

The Third Affiliated Hospital of Kunming Medical University

Collaborator

Kunming Medical University

Collaborator